Latest news
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 07:46:00 GMTIntellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates - Intellia TherapeuticsIntellia Therapeutics · Thu, 06 Aug 2026 11:05:12 GMTVivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 12:40:48 GMTVivos sleep apnea devices gain broader protection after new patent - Stock TitanStock Titan · Wed, 05 Aug 2026 12:30:00 GMT